Leonardi, Maria Cristina
Spoto, Ruggero
Miglietta, Eleonora
Trivellato, Sara
La Rocca, Eliana
Luraschi, Rosa
Grosso, Paola
De Lorenzi, Francesca
Fodor, Cristiana
Dicuonzo, Samantha https://orcid.org/0000-0003-4275-0080
Dell’Acqua, Veronica
Gerardi, Marianna Alessandra
Morra, Anna
Francia, Claudia Maria
Rietjens, Mario
Galimberti, Viviana Enrica
Veronesi, Paolo
Orecchia, Roberto
Cattani, Federica
Jereczek-Fossa, Barbara Alicja
Funding for this research was provided by:
Accuray Inc (grant for Data collection, analysis of Tomotherapy, CyberKnife breast clinical studies, breast physics studies, prostate study)
IEO Foundation (fellowship for Helical ALtered Fractionation for iMplant partial OmissiON): Implant sparing helical tomotherapy with hypofractionated scheme for intermediate/high risk breast cancer)
Article History
Received: 8 April 2019
Accepted: 16 May 2019
First Online: 29 May 2019
Compliance with ethical standards
:
: Leonardi MC, Dell’Acqua V, Cattani F, and Jereczek-Fossa BA received a speaker honorarium from Accuracy International. All other authors declare that they have no conflict of interest.
: All procedures performed in the present study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.The dosimetric study has been approved by the institutional Ethical Committee as part of the research project entitled “Adjuvant radiation treatments with intensity-modulated radiotherapy and/or hypofractionated schedules for breast cancer” (26 May 2016, Milan, Italy).
: Informed consent was obtained from all individual participants included in the study.